Future Planet Invests in Vaccitech’s Series B Financing

18 Mar, 2021

Future Planet Invests in Vaccitech’s Series B Financing
Photo by Macau Photo Agency on Unsplash

Future Planet Capital invests in a $168m Series B financing announced today by Vaccitech Ltd.
– Future Planet joins other leading investors including M&G Investment Management, Tencent, Gilead Sciences, Monaco Constitutional Reserve Fund and fellow existing investor, Oxford Sciences Innovation.
– As part of the Series B financing, $43m in convertible loan notes previously issued by Vaccitech will convert into Series B shares, resulting in total gross proceeds to Vaccitech of $168m before expenses.
Future Planet Capital is a London-based investment firm focused on venture capital and private equity investments in early stage life sciences companies.

Biotechnology Europe Health Care Medical Pharmaceutical Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: